{
    "2020-08-09": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|周报】A+H已成为大势，药筛CRO不断突破行业天花板",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "A+H",
                        "药筛CRO",
                        "行业天花板"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：医药“双循环” 看好创新药械进口替代+消费升级",
                "features": {
                    "keywords": [
                        "医药行业",
                        "双循环",
                        "创新药械",
                        "进口替代",
                        "消费升级"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821)半年报点评：运营回归高增长 持续看好后续发展",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "半年报",
                        "高增长",
                        "后续发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821)：Q2业绩恢复高增长 毛利率开始出现大幅改善",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "Q2",
                        "业绩",
                        "高增长",
                        "毛利率",
                        "大幅改善"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}